How many acquisitions has BioNTech made so far?

BioNTech has completed 5 acquisitions so far, with an average acquisition amount of $866M.

Which countries does BioNTech usually acquire in?

BioNTech has made acquisitions in 5 countries with the most activity in China and United Kingdom.

Which sectors does BioNTech target for acquisitions?

Most of BioNTech's acquisitions are in Oncology (3) and Immunotherapy (2).

In which year did BioNTech make the most acquisitions?

BioNTech was most active in 2025, with 1 acquisition completed in that year.

List of 5 Acquisitions by BioNTech (Nov 2026)

Q: Which is BioNTech's latest acquisition?

BioNTech's most recent acquisition is CureVac, a Developer of mRNA-based therapeutics against cancer and infectious diseases, acquired in June 2025.

Most viewed in 2019

BioNTech has made a total of 5 acquisitions. These were completed across 11 sectors, including Oncology, Infectious Diseases, and Immunotherapy, spanning 5 countries such as China, United Kingdom, and United States. Peak acquisition activity occurred in 2023, 2024, and 2025, with 1 acquisition recorded each year. The average number of acquisitions per year from 2020 to 2025 is 0.8, and 0 acquisitions have been completed in the current calendar year. The most recent acquisition, completed in June 2025, is CureVac; founded in 2000 and based in Tubingen, it develops mRNA-based therapeutics against cancer and infectious diseases.

Here's the year on year acquisition history of BioNTech:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2024	1
2023	1
2021	1
2020	1

View all Acquisitions by BioNTech

Recent acquisitions by BioNTech

BioNTech's most recent acquisition - CureVac is a Developer of mRNA-based therapeutics against cancer and infectious diseases, founded in 2000 and located in Tubingen. BioNTech acquired a 100% stake in it in June 2025 for a price of $*****.

Here is the list of all acquisitions by BioNTech sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jun 12, 2025	CureVac	fjjb	bzjr	73	330
Nov 13, 2024	Biotheus	mgiu	qcfm	73	719
Jan 10, 2023	InstaDeep	bvkj	ommn	47	825

View the full list of acquisitions

Media has covered BioNTech for a total of 59 events in the last 1 year, 6 of them have been about acquisition activity.

•

Big Pharma's M&A Firepower: J&J Poised for Acquisitions Amidst Sector ActivityBioSpace•Oct 28, 2026•BioNTech, Amgen, Roche, Johnson & Johnson

•

Boehringer Ingelheim to Evaluate Innovative Combination in Small Cell Lung CancerGlobeNewswire•Apr 09, 2026•BioNTech, Boehringer Ingelheim, Zai Lab

•

Novavax Enters License Agreement with Pfizer for Matrix-M Adjuvant TechnologyPR Newswire•Jan 20, 2026•Pfizer, Novavax, BioNTech

•

BioNTech Completes CureVac Acquisition, Strengthening mRNA PositionGlobeNewswire•Dec 18, 2025•CureVac, BioNTech

•

BioNTech Achieves Minimum Condition in CureVac Exchange OfferBenzinga•Dec 03, 2025•BioNTech, CureVac

•

CureVac Announces Q3 & First 9 Months 2025 Results and Provides Business UpdatesWebDisclosure•Nov 24, 2025•BioNTech, CureVac

View More BioNTech Recent News

View all Acquisitions by BioNTech

Acquisitions by BioNTech

List of BioNTech's Acquisitions

Recent acquisitions by BioNTech

News related to BioNTech's acquisitions

FAQs about Acquisitions by BioNTech